Who we are
Leadership

Leadership

Our team is focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships
Executive leadershipBoard of directors
John C. Jacobs
John C. Jacobs
President and Chief Executive Officer
John C. Jacobs full biography
John J. Trizzino
John J. Trizzino
President,
Chief Operating Officer
John J. Trizzino full biography
Mark Casey
Mark Casey
Executive Vice President,
Chief Legal Officer
Mark Casey full biography
Rick Crowley
Rick Crowley
Executive Vice President,
Chief Operations Officer
Rick Crowley full biography
Ruxandra Draghia-Akli, MD, PhD
Ruxandra Draghia-Akli, MD, PhD
Executive Vice President,
Head of Research & Development
Ruxandra Draghia-Akli, MD, PhD full biography
Jim Kelly
Jim Kelly
Executive Vice President,
Chief Financial Officer and
Treasurer
Jim Kelly full biography
Elaine O’Hara
Elaine O’Hara
Executive Vice President,
Chief Strategy Officer
Elaine O’Hara full biography
Silvia Taylor
Silvia Taylor
Executive Vice President,
Chief Corporate Affairs and Advocacy Officer
Silvia Taylor full biography
Henrietta Ukwu, MD
Henrietta Ukwu, MD
Executive Vice President,
Chief Regulatory Officer
Henrietta Ukwu, MD full biography
Ian Watkins
Ian Watkins
Executive Vice President,
Chief Human Resources Officer
Ian Watkins full biography
Troy Morgan, JD
Troy Morgan, JD
Senior Vice President
Deputy General Counsel & Chief Compliance Officer
Troy Morgan, JD full biography
Robert Walker, MD
Robert Walker, MD
Senior Vice President,
Chief Medical Officer
Robert Walker, MD full biography
John C. Jacobs
John C. Jacobs
President and Chief Executive Officer
John C. Jacobs full biography
Margaret G. McGlynn, R. Ph.
Margaret G. McGlynn, R. Ph.
Chairman of the Board of Directors
Margaret G. McGlynn, R. Ph. full biography
Gregg Alton
Gregg Alton
Director
Gregg Alton full biography
Richard Douglas, PhD
Richard Douglas, PhD
Director
Richard Douglas, PhD full biography
Rachel King
Rachel King
Director
Rachel King full biography
David Mott
David Mott
Director
David Mott full biography
Rick Rodgers, MBA
Rick Rodgers, MBA
Director
Rick Rodgers, MBA full biography
John Shiver, PhD
John Shiver, PhD
Director
John Shiver, PhD full biography

Corporate governance

Novavax’ Compliance program

Annual Declaration Clause for California (May 2024)

Novavax Inc. (Novavax) is committed to establishing and maintaining an effective compliance program that promotes conducting business activities in accordance with applicable laws, rules, and regulations, with the highest ethical standards in its interactions with all medical and health professionals and organizations. Novavax’ compliance program is designed to prevent, detect, and respond to potential instances of non-compliance. 

Novavax declares, in good faith as of May 24, 2024, that the company is in compliance with a Comprehensive Compliance Program and the requirements of the California Health & Safety Code §119400-119402. This declaration is based on Novavax’ review and understanding of the California Health & Safety Code §119400-119402 including the key components of a Comprehensive Compliance Program and the annual aggregate limit on promotional expenditures. Novavax will update this declaration on an annual basis. 

To obtain a written copy of our Code of Conduct or a written declaration of compliance, please contact 844-612-0252.

Careers

Build your future with us

Explore opportunities

Investors

Annual reports, events, and more

Visit the investors hub